Rumor is that Enzo is closing up shop and that guys small penis is gonna be a mouthful for that guys mother. Cheers.
In a letter to the board, Roumell says "The stock price has declined by nearly 70% since the beginning of 2018. In fact, Enzo’s stock trades below where it traded 20 years ago. We believe the time has come for the Board to recognize that the company is too small to be successful on its own." "We believe it’s likely that the company’s enviable product and IP portfolio would be better suited in a larger company’s hands, where Enzo’s promising AmpiProbe platform can go to market more efficiently and quickly," Roumell continues.
Can Roumell gain enough support to force multiple seats at the board? Roumell has 4% ownership, that means getting to the individual stock holders to force a sell off of the lab. Maybe Blackrock or one of the institutional investors get wind of the filing , but Barry and Elazar are already probably doing damage control saying Roumell doesn’t know what they are talking about. If you read the earnings report, Barry says another loss is expected on the clinical lab side. With another 10% cut in Medicare, The sabar rattle of Roumell May have some ears that were not previously listening. Does Elazar risk losing his position on the board, all the perks , to hold onto his brothers business? He never liked Sharam, and doesn’t like the clinical lab. Elazar May be tough, be he is a brilliant guy, and knows the board, he will know before anyone if it stays or goes. A share holder.
Good synergies for LabCorp as they need NY OB business. Easy tuck-in sale. Makes perfect sensethat they want it to happen .
